Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,445,445 papers from all fields of science
Search
Sign In
Create Free Account
CMV pp65 peptide
Known as:
CMV N495 Peptide
, CMV-PEP
A peptide derived from cytomegalovirus (CMV) internal matrix protein pp65. CMV pp65 peptide antigen is used in recombinant vaccinia virus as an HLA-A…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
autologous dendritic cells/CMV pp65 peptide
autologous dendritic cells/carcinoembryonic antigen peptide 1-6D/CMV pp65 peptide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
S. Weisberg
,
E. Staley
,
+5 authors
B. Shaz
Archives of Pathology & Laboratory Medicine
2017
Corpus ID: 27144020
CONTEXT - Cytomegalovirus (CMV) can be transmitted by cellular blood products, leading to severe disease in immunosuppressed…
Expand
2012
2012
Construction of a recombinant lentivirus containing human microRNA-7-3 and its inhibitory effects on glioma proliferation
Lun Dong
,
Chongxu Han
,
+4 authors
Xiao-dong Wang
Neural Regeneration Research
2012
Corpus ID: 21783754
In the present study, we constructed a lentivirus, FIV-CMV-GFP-miR-7-3, containing the microRNA-7-3 gene and the green…
Expand
2005
2005
A Novel Mutation in the Ul54 Gene of Human Cytomegalovirus Isolates that Confers Resistance to Foscarnet
A. Ducancelle
,
G. Champier
,
S. Alain
,
F. Petit
,
M. S. Le Pors
,
M. Mazeron
Antiviral Therapy
2005
Corpus ID: 37662662
Foscarnet is currently licensed for the treatment of human cytomegalovirus (HCMV) infection. Mutations proven to confer…
Expand
2005
2005
Characterization of host immunity to cytomegalovirus pp150 (UL32).
C. La Rosa
,
Zhongde Wang
,
+5 authors
D. Diamond
Human Immunology
2005
Corpus ID: 26704860
2004
2004
DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice.
G. Gallez-Hawkins
,
Xiuli Li
,
+4 authors
J. Zaia
Vaccine
2004
Corpus ID: 33904290
2004
2004
[Influence of ganciclovir and astragalus membranaceus on proliferation of hematopoietic progenitor cells of cord blood after cytomegalovirus infection in vitro].
Wen-jun Liu
,
B. Liu
,
+5 authors
Jiang Lin
Zhonghua er ke za zhi = Chinese journal of…
2004
Corpus ID: 24479224
OBJECTIVE Cytomegalovirus (CMV) infection was greatly common in the world. CMV infection produces usually mild or asymptomatic…
Expand
2003
2003
Multiplex polymerase chain reaction for the detection of herpes simplex virus, varicella-zoster virus and cytomegalovirus in ocular specimens
G. Chichili
,
S. Athmanathan
,
+4 authors
Savitri Sharma
Current Eye Research
2003
Corpus ID: 25124553
Purpose. A majority of ocular viral diseases are caused by herpes group of viruses. Such infections, especially atypical herpetic…
Expand
Highly Cited
2003
Highly Cited
2003
Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment
M. Engstrand
,
A. Lidehäll
,
T. Tötterman
,
B. Herrman
,
B. Eriksson
,
O. Korsgren
Clinical and Experimental Immunology
2003
Corpus ID: 28332879
The availability of tetrameric complexes of HLA class I molecules folded with immunodominant peptides makes it possible to…
Expand
Highly Cited
2000
Highly Cited
2000
Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene delivery
J. Cho
,
S. Xing
,
+5 authors
S. Jhiang
Gene Therapy
2000
Corpus ID: 36524582
Radioiodide concentrating activity in the thyroid, mediated by human Na+/I− symporter (hNIS), provides a mechanism for effective…
Expand
1999
1999
pFab-CMV, a single vector system for the rapid conversion of recombinant Fabs into whole IgG1 antibodies.
P. Sanna
,
M. Samson
,
+4 authors
D. Burton
Immunotechnology
1999
Corpus ID: 4573997
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE